The prostate cancer prevention trial: Current status and lessons learned

Urology

Volumn 57, Issue 4, 2001, Pages 230-234

  Thompson, Ian M ^a,b,c,d   Kouril, Margaret ^a,b,c,d   Klein, Eric A ^a,b,c,d   Coltman, Charles A ^a,b,c,d   Ryan, Anne ^a,b,c,d   Goodman, Phyllis ^a,b,c,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Southwest Oncology Group   (United States)

^d SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE;

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PALPATION; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL;

ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; PALPATION; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0035320033     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00980-8     Document Type: Article

References (8)

1. Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
2. Thigpen TE, Davis DL, Gautier T, et al: Brief report: the molecular basis of steroid five alpha-reductase deficiency in a large Dominican kindred. N Engl J Med 327: 1216-1219, 1992.
3. Imperato-McGinley J, Gautier T, Zirinsky K, et al: Prostate visualization studies in males homozygous and heterozygous for five alpha-reductase deficiency. J Clin Endocrinol Metab 75: 1022-1026, 1992.
4. Thompson IM, Coltman CA Jr, and Crowley J: Chemoprevention of prostate cancer: The Prostate Cancer Prevention Trial. Prostate 33: 217-221, 1997.
5. Ellis L and Nyborg H: Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 57: 72-75, 1992.
6. Ross RK, Bernstein L, Lobo RA, et al: 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339: 887-889, 1992.
7. Cooner WH, Mosely BR, Rutherford CL, et al: Clinical application of TRUS and PSA in the search for prostate cancer. J Urol 139: 758-761, 1988.
8. Levine MA, Ittman M, Melamed J, et al: Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159: 471-475, 1998.